Patrocinado
Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol
Postado
Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving effective against both Ogawa and Inaba serotypes. The vaccine exhibited a significant rise in vibriocidal antibodies and maintained a strong safety profile across all age groups. With production capacity of 200 million doses, Hillchol can address the global cholera crisis and vaccine shortages.
Pesquisar
Categorias
- National
- International
- Business
- Technology
- Health
- Educação
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Leia Mais
‘100 per cent’: Musk says his America Party will expose Epstein files; deepens rift with Trump
Elon Musk has declared that exposing the Jeffrey Epstein files will be a "top priority" for his...
FIFA CWC: Joao Pedro brace sends Chelsea into final, beat Fluminense 2-0
Joao Pedro, Chelsea's recent £60 million acquisition, showcased his prowess with a stunning...
'He panicked, he blundered': Gayle slams Mulder for not chasing Lara’s record
Wiaan Mulder's record-breaking 367* against Zimbabwe was overshadowed by his decision to declare,...
Floods and landslides block 10 major highways across Nepal
KATHMANDU: Continuous rainfall has triggered floods and landslides across the country,...
© 2025 Dununu.com : Circle of Life - Santan Social Network
Portuguese
